Javier Cortés

机构：Universitat de Girona, Boiron (France), Hospital Universitario de Torrejón, MedSIR (Spain), Hospital Quirónsalud Barcelona, International Breast Cancer Study Group, Vall d'Hebron Institute of Oncology, IDCQ Hospitales y Sanidad, S.L.U., Universidad Europea de Madrid · ORCID：0000-0001-7623-1583

发表论文 1511 篇 · 总被引 73780 次 · h-index 116

代表论文

• Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial (2026 · Annals of Oncology · 被引 17)
• Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: results from the randomised, global phase III CAPItello-290 trial (2025 · Annals of Oncology · 被引 6)
• Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies (2025 · The Oncologist · 被引 6)
• Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer (2025 · Clinical Cancer Research · 被引 3)
• A chemotherapy-free, pathological response-adapted strategy using trastuzumab–pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study (2026 · Annals of Oncology · 被引 2)
• Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study (2026 · Annals of Surgical Oncology · 被引 2)